Evidence map›Paper›PMID 31239045›Full record

ArticleMethods in enzymology2019

Synthetic bPNAs as allosteric triggers of hammerhead ribozyme catalysis.

Yufeng Liang, Jie Mao, Dennis Bong

Abstract read
In one paragraph

Article in Methods in enzymology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Synthesis of Bifacial Peptide Nucleic Acids with Diketopiperazine Backbones.Synlett : accounts and rapid communications in synthetic organic chemistry · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yufeng LiangDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, United States.
Jie MaoDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, United States.
Dennis BongDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, United States. Electronic address: bong.6@osu.edu.

Funding

Development of Fluorogenic Aptamers for Detection and Deactivation of Erbb Receptors using Bifacial PNAR01GM111995 · NIGMS · OHIO STATE UNIVERSITY · PI BONG, DENNIS · 2015 to 2019
$1.4M
NIGMS NIH HHS R01 GM111995
6 · The paper itself

Abstract

The biochemistry and structural biology of the hammerhead ribozyme (HHR) have been well elucidated. The secondary and tertiary structural elements that enable sugar-phosphate bond scission to be catalyzed by this RNA are clearly understood. We have taken advantage of this knowledge base to test the extent to which synthetic molecules, may be used to trigger structure in secondary structure and tertiary interactions and thereby control HHR catalysis. These molecules belong to a family of molecules we generally call "bPNAs" based on our work on bifacial peptide nucleic acid (bPNA). This family of molecules displays the "bifacial" heterocycle melamine, which acts as a base-triple upon capturing two equivalents of thymine or uracil. Loosely structured internal oligouridylate bulges of 4-20 nucleotides can be restructured as triplex hybrid stems upon binding bPNAs. As such, a duplex stem element can be replaced with a bPNA triplex hybrid stem; similarly, a tertiary loop-stem interaction can be replaced with a loop-bPNA-stem complex. The ability to control RNA structure-function facilitates elucidation of these critical aspects of RNA recognition. In this chapter, we discuss how bPNAs are prepared and applied to study structure-function turn on in the hammerhead ribozyme system.

Indexed as

Allosteric RegulationBiocatalysisChemistry Techniques, SyntheticChromatography, High Pressure LiquidPeptide Nucleic AcidsRNA, Catalytichammerhead ribozymePeptide Nucleic AcidsRNA, CatalyticAllostericBase-triplebPNAHammerheadNucleic acid mimicRNASwitchTriplex

Identifiers

PMID31239045
PMCPMC7023910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.